Advertisement

Topics

Latest "Human medicines European public assessment report EPAR Odefsey" News Stories

16:39 EDT 23rd March 2019 | BioPortfolio

Here are the most relevant search results for "Human medicines European public assessment report EPAR Odefsey" found in our extensive news archives from over 250 global news sources.

More Information about Human medicines European public assessment report EPAR Odefsey on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Human medicines European public assessment report EPAR Odefsey for you to read. Along with our medical data and news we also list Human medicines European public assessment report EPAR Odefsey Clinical Trials, which are updated daily. BioPortfolio also has a large database of Human medicines European public assessment report EPAR Odefsey Companies for you to search.

Showing "Human medicines European public assessment report EPAR Odefsey" News Articles 1–25 of 38,000+

Saturday 23rd March 2019

Steam Dried Fishmeal Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Steam Dried Fishmeal report provides an independent information about the Steam Dried Fishmeal industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent development...


Matthew Porteus is wrapping up the Henry Kunkel Society Meeting with a talk on #genome editing for disease treatment. Check out his paper on a high on-target activity Cas9 variant that corrects the #sickle cell disease mutation in human #stem cells https:

Matthew Porteus is wrapping up the Henry Kunkel Society Meeting with a talk on #genome editing for disease treatment. Check out his paper on a high on-target activity Cas9 variant that corrects the #sickle cell disease mutation in human #stem cells https://go.nature.com/2U2ETRU 

Opinion: “Global warming is the biggest public health threat of the 21st century and is going to change life on earth as we know it. It is an essential part of any 21st century medical school curriculum." https://buff.ly/2YfXJEk 

Opinion: “Global warming is the biggest public health threat of the 21st century and is going to change life on earth as we know it. It is an essential part of any 21st century medical school curriculum." https://buff.ly/2YfXJEk 


Eggs and Heart Disease; ADHD and Psychosis: It's PodMed Double T! (with audio)

(MedPage Today) -- This week's topics include best medicines for atrial fibrillation when a stent is used, an envelope for cardiac devices to reduce infection risk, psychosis and ADHD medicines, and eggs and cardiovascular disease

According to a new study, people who take certain #ADHD medicines may be at a higher risk of having a psychotic event than others. https://buff.ly/2TQyQjO 

According to a new study, people who take certain #ADHD medicines may be at a higher risk of having a psychotic event than others. https://buff.ly/2TQyQjO 

City of Hope Study Finds Popular Diabetes Diagnosis Test Misses Most Cases

The study was presented at ENDO 2019, Endocrine Society’s annual meeting The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes, but it is actually unable to detect the disease in most patients, according to a new study presented Saturday, March 23, at a news conference at ENDO 2019, the Endocrine Society’s annual meeti...

Diagnosing autism: many nations, one world

I pause for a moment and close my eyes — to center myself in this country, where I am today.   I am about to walk through the door and tell the parents what my assessment has shown. I nod to the interpreter waiting behind me and knock firmly before entering the room.  You see, I […] Find jobs at Careers by KevinMD.com. Search thousands of physician, PA, NP, and CRNA jobs now. Lea...

How social media can help or hurt your health care career

This article is sponsored by Careers by KevinMD.com. We live in a time when social media isn’t just about sharing pictures or ideas with a close circle of friends and family. Between our Facebook statuses, our Twitter profiles and especially our LinkedIn pages, we are always public, all the time — no matter what your privacy settings may have […] Find jobs at Careers by KevinMD.com....

News digest – hot tea, cancer doctor shortages, junk food ad ban proposals and baby Grady  

Science blog Hot tea headlines miss crucial details Hot drinks hit the headlines this week after a study sparked claims that hot

Could Crocus Sativus (Saffron) Be as Effective as Stimulant Medicines in Treating #ADHD? http://ow.ly/575030o9UMv pic.twitter.com/eDrkyzGaRX

Could Crocus Sativus (Saffron) Be as Effective as Stimulant Medicines in Treating #ADHD? http://ow.ly/575030o9UMv  pic.twitter.com/eDrkyzGaRX

Friday 22nd March 2019

Medical News Today: Can scientists learn to remove bad memories?

New research in human participants explores a novel intervention that aims to weaken traumatic memories and lessen their psychological impact.

Interactions of an Emerging Fungal Pathogen Scedosporium aurantiacum with Human Lung Epithelial Cells

Engineers at @RutgersU report the creation of flexible, lightweight materials with 4D printing that could lead to small implantable biomedical devices (with video): http://ow.ly/ep1r30o9re9 

Engineers at @RutgersU report the creation of flexible, lightweight materials with 4D printing that could lead to small implantable biomedical devices (with video): http://ow.ly/ep1r30o9re9 

Bisphosphonates increasingly prescribed to the women most likely to benefit

(The Endocrine Society) In recent years, women who start taking bisphosphonates (BPs) to treat osteoporosis and prevent fracture have trended from younger to older and from having osteopenia to having osteoporosis, researchers report. The results of the study will be presented on Saturday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

For migraine sufferers with obesity, losing weight can decrease headaches

(The Endocrine Society) For migraine sufferers with obesity, losing weight can decrease headaches and improve quality of life, researchers from Italy and the United States report. The results of their meta-analysis will be presented Saturday, March 23 at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

New evidence on the role of the gut microbiome in improving human health

(American Gastroenterological Association) The gut microbiome is one of the fastest moving areas of science today. Twenty-three new abstracts highlighting the most cutting-edge advances in gut microbiome research will be presented at the eighth annual Gut Microbiota for Health World Summit, March 23-24, 2019, in Miami, Fla.

Regenerative Fuel Cell RFC Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe Regenerative Fuel Cell RFC report provides an independent information about the Regenerative Fuel Cell RFC industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including business overview and recent...

AAHRPP Accredits Three More Research Organizations

Two in the U.S., one in Taiwan attain the gold standard WASHINGTON, March 22, 2019 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs today announced its first accreditations for 2019: a research institute in Massachusetts, a health care delivery system in California and a hospital in Taiwan. The three newly accredited organiza...

Navidea Biopharmaceuticals Announces Stock Purchase Agreement; Other Business Updates

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced execution of a Stock Purchase Agreement (the “Purchase Agreement”) with an existing investor, John K. Scott, Jr. (the “Investor”), pursuant to ...

Dr. Srini Pillay, Best-Selling Author, Examines the Plight of Millennials

“Many of my clients who fall into the same age group as millennials are lost, overwhelmed, confused about their careers, and lonelier than ever.” – Dr. Srini Pillay BOSTON (PRWEB) March 22, 2019 Dr. Srini Pillay, a best-selling author, neuroscientist, tech entrepreneur and an assistant professor at Harvard University, has spent a large chunk of his career subverting ideas on creativity and ...

Society for Immunotherapy of Cancer Announces 2019 Recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship

The Society for Immunotherapy of Cancer (SITC) is pleased to announce Olivera J. Finn, PhD, University of Pittsburgh Distinguished Professor of Immunology and Surgery and Founding Chair of the university’s Department of Immunology, as the 2019 recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship, the society’s highest honor. MILWAUKEE (PRWEB) March 22, 2019 The Society for ...

EU Approval Sought for Frontline Daratumumab/Rd in Transplant-Ineligible Myeloma

A Type II variation application has been submitted to the European Medicines Agency for the combination of daratumumab with lenalidomide and dexamethasone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation.

Gossamer Bio Announces 2018 Annual Financial Results

Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the year ended December 31, 2018 and provided an update on recent corporate developments. ...

Teva Announces Launch of a Generic Version of EXJADE® (deferasirox) Tablets For Oral Suspension in the United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets for Oral Suspension are an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in ...

Titan Medical nets $26.7mm via public offering

Titan Medical Inc. (robotic system for minimally invasive surgery) grossed $26.7mm through the overnight marketed offering of...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks